Birgit Funke
Cardiology and Cardiovascular Medicine · 2001–2018
A researcher in the Science corpus: 11 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Cardiology and Cardiovascular Medicine — 83 citations into it
Whom Birgit Funke trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Birgit Funke's perspective
Ordered by how strongly the researchers Birgit Funke trusts endorse each paper. Same corpus, a different order for every researcher.
- The effect of cardiac resynchronization on morbidity and mortality in heart failure. (New England Journal of Medicine)
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
- Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. (New England Journal of Medicine)
- Hypertrophic cardiomyopathy: a systematic review.
- ACMG clinical laboratory standards for next-generation sequencing (Genetics in Medicine)
- Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral (Journal of Medical Genetics)
- Does sports activity enhance the risk of sudden death in adolescents and young adults? (Journal of the American College of Cardiology)
- Cardiac-resynchronization therapy for the prevention of heart-failure events. (New England Journal of Medicine)
- Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations (Nature Genetics)
- Sarcomere Protein Gene Mutations in Hypertrophic Cardiomyopathy of the Elderly
Their papers
- TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. (2001) — 962 citations
- Using high-resolution variant frequencies to empower clinical genome interpretation (2016) — 413 citations
- Adaptation and Validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: Recommendations by ClinGen’s Inherited Cardiomyopathy Expert Panel (2018) — 334 citations
- Genetic Misdiagnoses and the Potential for Health Disparities (2016) — 683 citations
- Reassessment Of Mendelian Gene Pathogenicity Using 7,855 Cardiomyopathy Cases And 60,706 Reference Samples (2016) — 703 citations
- Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity (2015) — 447 citations
- The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing (2014) — 349 citations
- A systematic approach to assessing the clinical significance of genetic variants (2013) — 182 citations
- ACMG clinical laboratory standards for next-generation sequencing (2013) — 907 citations
- Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts. (2012) — 134 citations
- Dilated Cardiomyopathy (2007) — 1,054 citations